当前位置:首页 - 行情中心 - 亚太药业(002370) - 财务分析 - 现金流量表

亚太药业

(002370)

  

流通市值:65.54亿  总市值:65.54亿
流通股本:7.46亿   总股本:7.46亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金146,928,758.5689,348,452.0839,441,013.53253,785,396.08
  收到其他与经营活动有关的现金36,121,132.6835,185,164.715,740,593.812,249,568.38
  经营活动现金流入小计183,049,891.24124,533,616.7855,181,607.33266,034,964.46
  购买商品、接受劳务支付的现金53,945,864.3926,748,846.049,510,992.1472,607,975.52
  支付给职工以及为职工支付的现金51,439,097.136,570,938.1621,021,711.569,459,330.28
  支付的各项税费14,931,678.167,459,829.035,865,391.8822,792,945.92
  支付其他与经营活动有关的现金39,184,293.4125,857,352.367,208,712.6876,821,604.42
  经营活动现金流出小计159,500,933.0696,636,965.5943,606,808.2241,681,856.14
  经营活动产生的现金流量净额23,548,958.1827,896,651.1911,574,799.1324,353,108.32
二、投资活动产生的现金流量:
  收回投资收到的现金31,175,934.55329,615.14329,615.14903,131.26
  取得投资收益收到的现金912,448.6910,465.4-16,023,045.73
  处置固定资产、无形资产和其他长期资产收回的现金净额7,9007,900--122,858.49
  处置子公司及其他营业单位收到的现金净额126,268,279.93126,268,279.9330,000,000-
  收到的其他与投资活动有关的现金50,767,599.9650,675,408.161,924,030.27-
  投资活动现金流入小计209,132,163.04178,191,668.6332,253,645.4116,803,318.5
  购建固定资产、无形资产和其他长期资产支付的现金4,351,564.632,244,962417,4549,794,862.2
  投资支付的现金60,000,000---
  投资活动现金流出小计64,351,564.632,244,962417,4549,794,862.2
  投资活动产生的现金流量净额144,780,598.41175,946,706.6331,836,191.417,008,456.3
三、筹资活动产生的现金流量:
  取得借款收到的现金---30,000,000
  筹资活动现金流入平衡项目-0-0
  筹资活动现金流入小计-0-30,000,000
  偿还债务支付的现金277,225,300277,225,300-50,000,000
  分配股利、利润或偿付利息支付的现金37,371,378.3437,371,378.34246,500.0111,901,761.8
  支付其他与筹资活动有关的现金---3,604.42
  筹资活动现金流出小计314,596,678.34314,596,678.34246,500.0161,905,366.22
  筹资活动产生的现金流量净额-314,596,678.34-314,596,678.34-246,500.01-31,905,366.22
五、现金及现金等价物净增加额-146,267,121.75-110,753,320.5243,164,490.53-543,801.6
  加:期初现金及现金等价物余额719,698,723.26719,698,723.26719,698,723.26720,242,524.86
  期末现金及现金等价物余额573,431,601.51608,945,402.74762,863,213.79719,698,723.26
补充资料:
  净利润-105,176,469.82-34,239,781.33
  资产减值准备-5,029,349-5,563,928.48
  固定资产和投资性房地产折旧-14,227,000.21-31,172,474.31
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,227,000.21-31,172,474.31
  无形资产摊销-2,896,448.04-5,753,973.97
  长期待摊费用摊销-100,440-208,758.69
  处置固定资产、无形资产和其他长期资产的损失---7,367.1
  固定资产报废损失-19,076.46-127,358.49
  公允价值变动损失--952,429.21--1,638,089.72
  财务费用-34,642,973.19-30,590,222.13
  投资损失--150,281,649.56--53,816,793.8
  递延所得税-142,864.37-245,713.46
    递延所得税负债增加-142,864.37-245,713.46
  存货的减少-1,330,008.62-13,816,027.95
  经营性应收项目的减少--630,494.73-3,541,510.73
  经营性应付项目的增加-17,061,757.18--45,491,317.36
  债务转为资本---358,259,900
  现金的期末余额-608,945,402.74-719,698,723.26
  减:现金的期初余额-719,698,723.26-720,242,524.86
  现金及现金等价物的净增加额--110,753,320.52--543,801.6
公告日期2025-10-292025-08-302025-04-302025-04-25
审计意见(境内)标准无保留意见
TOP↑